◆ SpookStack

TeghpjsebPedb Fair Reheaises 209 0K08/ 08.u dA BRR96-00789R003100140001 -2 DRAFT lil. APPROACH rrr 1. Receiver Selection We will use two specialize populations from which to draw receivers for this pilot experiment: (1) Experienced dreamers from LaBerg’s research subjects , and (2) Receivers who have demonstrated significant ability in other AC studies. Currently, five and seven individuals have volunteered, respectively. 2. Target Selection Targets will be chosen randomly from the standard set of 100 National Geographic magazine photographs. 3. Trial Definition A trial is defined as a successful lucid dream during which the target material was examined and later transcribed in the waking state. 4. Lucid Dream Protocol All receivers will undertake two forms of training in lucid dreaming: (1) They will complete a lucid dreaming home-study course developed by the Lucidity Institute (i.e., a subcontractor to SAIC), and (2) they will attend two weekend seminars, one at the beginning and one at the end of the proposed three-month pilot study. The first seminar, which was held in December, 1991, introduced receivers to lucid dreaming skills and the the use of the DreamLight, a lucid dream induction device. In previous studies, the DreamLight has been shown to enhance the frequency of lucid dreaming. The DreamLight consists of a sleep mask equipped with lights and eye movement sensors, which are attached to a small battery-operated computer. When the computer detects the eye movements of dreaming (i.e., REM) sleep, it causes the lights in the mask to flash briefly (i.e., either one or two flashes per second). The dreamer frequently incorporates the flashes into the ongoing dream, and thus experiences a cue to indi- cate that he or she is dreaming. Receivers will have free access to DreamLights during the duration of the study. 5. AC Baseline Measures Each receiver will be asked to contribute eight trials in a waking state in the Cognitive Sciences Labora- tory as an AC baseline series. The targets for this series will be chosen at random from a standardized target set that was developed from an earlier program. Each trial will be conducted as follows: After the Approved For Release AQ pasnnton, DHAEPP26-00789R0031 00140001 -2